Edmonton
Canada
7
2025-02-06
1
2019-11-12
These are the the leading inventors for applications assigned to Aurinia Pharmaceuticals Inc.:
Aurinia Pharmaceuticals Inc. based in Edmonton, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
B CELL ACTIVATING FACTOR (BAFF)-A PROLIFERATION INDUCING LIGAND (APRIL) DUAL INHIBITORS
#2 | 2023-11-30PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY
#3 | 2017-12-21 ✅ Patent 10,472,394 granted on 2019-11-12Cyclosporine analogue mixtures and their use as immunomodulating agents
#4 | 2014-09-25Synthesis of Cyclosporin Analogs
#5 | 2014-09-04CYCLOSPORIN ANALOG FORMULATIONS
#6 | 2014-08-21Deuterated Cyclosporine Analogs and Methods of Making the Same
#7 | 2014-05-22CYCLOSPORINE ANALOGUE MIXTURES AND THEIR USE AS IMMUNOMODULATING AGENTS
Also check out Aurinia Pharmaceuticals Inc.'s (Edmonton, Canada) applicant profile with 3 patent applications submitted.
65692 ⎘